Ohio Infertility Prevention Project
This report summarizes the outcomes of the Ohio Infertility Prevention Project (IPP) Advisory Committee meeting held on June 9-10, 2010. The committee reviewed 84 sites operating in 2010, including family planning and STD clinics, and juvenile detention centers. Key statistics for 2009 include 69,132 chlamydia tests performed with an 8.9% positivity rate, and 60,334 gonorrhea tests with a 2.9% positivity rate. Challenges include reduced funding for STD medications and testing site capacity, while future strategies focus on program assessment and enhanced social marketing awareness.
Ohio Infertility Prevention Project
E N D
Presentation Transcript
OhioInfertility Prevention Project State Report Region V IPP Advisory Committee Meeting June 9-10, 2010
Overview • 84 sites for 2010 • 37 Family Planning Clinics, 35 STD Clinics, 11 Juvenile Detention Centers, and 1 Adult Correctional Facility • 4% chlamydia positivity rate required by the State Alliance for participation in the IPP. • 1% gonorrhea positivity rate required by the State Alliance for participation in the IPP. • 21 sites perform only CT testing due to falling below the 1% GC positivity for 12 months.
2009 Ohio IPP StatisticsChlamydia • 69,132 chlamydia tests were performed • 6,143 positive chlamydia tests were diagnosed • 8.9 % positivity rate
2009 Ohio IPP StatisticsGonorrhea • 60,334 gonorrhea tests were performed • 1,773 positive gonorrhea tests were diagnosed • 2.9% positivity rate
Screening Criteria • For 2009, the Ohio IPP changed the screening criteria to test anyone 29 years of age or younger. • 15 STD sites have special screening criteria allowing to test anyone 39 years of age or younger. • Revising the screening criteria for 2009 has shown success. • CT: 8.1% in 2008 to 8.9% in 2009 • GC: 2.8% in 2008 to 2.9% in 2009
Challenges • IPP Coordinator retired as of June 1, 2010. • State funding for STD medications has been cut from $200,000 a few years ago to $50,000. • More sites would like to offer urine testing but increased cost and lab capacity make this difficult. • EPT is still prohibited in Ohio.
Future Strategies • During the last half of 2010, a total program assessment will be conducted. • Location of IPP sites • Costs and quantity of testing • Social Marketing Campaign • Focus on talking to sex partners and encouraging testing • EPT Pilot Project • Temporary Ohio Administrative Code rule change
Contact Jen Keagy, MPH, CHES STD Program Manager 614.466.3173 Jen.Keagy@odh.ohio.gov Rhiannon Richman, MPH Epidemiologist 614.387.7475 Rhiannon.Richman@odh.ohio.gov
